- DDTR is an Official Journal of the Controlled Release Society, published by Springer Nature, focused on translational aspects of drug delivery
- María José Alonso is current President of the Controlled Release Society
María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC) and current President of the Controlled Release Society (CRS, Inc) is the new Editor-in-Chief of Drug Delivery and Translational Research (DDTR), an Official Journal of the Controlled Release Society published by Springer Nature.
Professor Alonso has published an editorial in the journal on the occasion of her designation to this position that can be found at this link.
The same information in a video format can be found at this link.
About DDTR
Focused on translational aspects of drug delivery, this journal provides a unique forum for publication of high-quality research.
Drug Delivery and Translational Research publishes research articles oriented to the design and development of novel drug delivery systems, with a focus on their application to disease conditions; preclinical and clinical data related to drug delivery systems; short-term and long-term biocompatibility of drug delivery systems, host response; biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering; image-guided drug therapy; nanomedicine; devices for drug delivery and drug/device combination products.
In addition to original full-length papers, communications, and reviews, the journal includes editorials, inspirational notes, research highlights, and announcements pertaining to activities of the Controlled Release Society. In addition, the journal publishes special issues dedicated to the Focus Groups and Local Chapters of the Controlled Release Society.
The journal counts on an oustanding team of editors representing all continents and an excellent editorial board.
Alonso’s research trajectory
María José Alonso’s lab (https://www.usc.gal/grupos/mjalonsolab/) has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. Currently, she is involved in 7 international projects. She is the author of over 267 scientific contributions with more than 16,400 cites (H factor 71) and the inventor of 20 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010). She is currently President of the Controlled Release Society.
She also serves on the editorial board of 11 journals. In 2006-10, she was the Vice-rector of Research and Innovation of the USC. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and of the Controlled Release Society, a member of three Academies in Spain and a member of the US National Academy of Medicine (NAM).
A long commitment with the CRS
Professor Alonso has held responsibilities in several scientific societies, among them the CRS. She first contributed to the CRS as the Founder of the Spanish-Portuguese Local Chapter (1994), later as a Governor (1995), as a member of the Board of Scientific Advisors (2012), as a Director-at-Large (2013), as a Secretary (2016) and, since 2017, as a President Elect.
The Controlled Release Society (CRS) is a global organization whose main goal is “Advancing delivery science and technology to solve global challenges”. In that sense, CRS, the leading worldwide society in this field, gathers delivery scientists, engineers, clinicians, and technical professionals in a multidisciplinary network oriented to broaden the knowledge and the applications of delivery science and technology.
.
